Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Sunday. The firm set a “sell” rating on the stock.

Streamline Health Solutions Trading Up 17.2 %

Shares of STRM opened at $4.29 on Friday. Streamline Health Solutions has a fifty-two week low of $1.85 and a fifty-two week high of $9.75. The business has a 50-day moving average of $3.04 and a 200 day moving average of $4.84. The firm has a market cap of $18.33 million, a P/E ratio of -0.87 and a beta of 1.67. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Monday, December 16th. The company reported ($0.61) earnings per share for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.